Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAVOLTA II: Lebrikizumab in Uncontrolled Asthma
NCT01868061Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2013
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 26
01
Overview
A Phase 3 trial of lebrikizumab in asthma, sponsored by Roche. Started Jul 2013; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01868061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868061.